Shilpa Medicare Ltd. shares rose nearly 5% on Wednesday after it received approval to manufacture and test oral mouth dissolving films from Therapeutic Goods Administration of Australia.
The company's Unit VI in Bengaluru's Dabaspet got approval to manufacture, package, label, and test oral mouth dissolving films from the Australian authority. The unit also manufactures transdermal patches, an exchange filing said. The company also has pipeline products in this segment.
Oral mouth dissolving films is niche dosage, which is more effective than normal oral dosages.
Shares of the company rose as much as 4.89%, before paring gains to trade 1.76% higher at 10:51 a.m., compared to a 4.7% decline in the NSE Nifty 50.
The stock has risen 34.97% year-to-date. Total traded volume so far in the day stood at 7.3 times its 30-day average. The relative strength index was at 55.68.
RECOMMENDED FOR YOU
Lupin Shares Jump Over 3% As Investec Hikes Target Price, Upgrades To 'Buy'
Sep 12, 2025
Lookout Notice Against Shilpa Shetty, Raj Kundra In Rs 60-Crore Cheating Case
Sep 05, 2025
Netweb Tech Shares Jump 8% On Rs 1,734-Crore Next-Gen AI Order
Sep 03, 2025
Japanese Lender SMBC's Stake Acquisition In Yes Bank Gets CCI Nod
Sep 02, 2025
POPULAR